Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Laura Moulton Chambers

9PUBLICATIONS

37CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCancer geneticsObstetrics and gynaecologyLiterature in Japanese

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jan 23, 2026

Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer.

Laura M Chambers, Julia Chalif, Meng Yao

|Apr 25, 2024

Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology Research.

Laura Chambers, Paulina Haight, Julia Chalif

|Oct 07, 2022

Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.

Laura M Chambers, Emily L Esakov Rhoades, Rashmi Bharti

|Jun 14, 2021

The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Laura M Chambers, Parker Bussies, Roberto Vargas

|Oct 03, 2019

Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer.

Laura Moulton Chambers, Ji Son, Milena Radeva

|Jul 04, 2019

Authors' reply re: Plagiarism and data falsification are the most common reasons for retracted publications in obstetrics and gynaecology.

Laura M Chambers, Chad M Michener, Tommaso Falcone

Pageof 2

Frequent Collaborators

4 joint publications

Roberto Vargas

3 joint publications

Chad M Michener

2 joint publications

Julia Chalif

2 joint publications

Ofer Reizes

2 joint publications

Peter Rose

1 joint publications

Paulina Haight

1 joint publications

Yogita Mehra

1 joint publications

Floor J Backes

1 joint publications

Casey M Cosgrove

1 joint publications

David M O'Malley

Frequent Collaborators

4 joint publications

Roberto Vargas

3 joint publications

Chad M Michener

2 joint publications

Julia Chalif

2 joint publications

Ofer Reizes

Top Related Videos

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on : Aug 28, 2012

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on : Aug 28, 2012

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research

Published on : Aug 15, 2019

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos